CEACAM1, a novel serum biomarker for pancreatic cancer.
作者： Diane M Simeone , Baoan Ji , Mousumi Banerjee , Thiruvengadam Arumugam , Dawei Li
DOI: 10.1097/MPA.0B013E3180333AE3
关键词:
摘要: Objectives:Serum biomarkers for early diagnosis of pancreatic adenocarcinoma are not currently available. We recently observed elevated expression CEACAM1 in adenocarcinomas and sought to determine whether serum levels were cancer patients.Methods:CEACAM1
elsevier.com
vietsciences.org参考文章(40)
Steinberg W, The clinical utility of the CA 19-9 tumor-associated antigen The American Journal of Gastroenterology. ,vol. 85, pp. 350- 355 ,(1990)
J. Götze, J. Brümmer, T. Löning, L. Riethdorf, P. Nollau, M. Naumann, C. Wagener, H. M. Schulte, A. M. Bamberger, I. Erdmann, Dysregulated expression of CD66a (BGP, C-CAM), an adhesion molecule of the CEA family, in endometrial cancer. American Journal of Pathology. ,vol. 152, pp. 1401- 1406 ,(1998)
D. I. Kleinerman, E. R. Sherwood, P. Troncoso, A. C. Von Eschenbach, L. L. Pisters, Sue-Hwa Lin, Jer-Tsong Hsieh, T. Brooks, Consistent Expression of an Epithelial Cell Adhesion Molecule (C-CAM) during Human Prostate Development and Loss of Expression in Prostate Cancer: Implication as a Tumor Suppressor Cancer Research. ,vol. 55, pp. 1215- 1220 ,(1995)
M Neumaier, U Fenger, C Wagener, A Stoffel, Z Drzeniek, H D Haubeck, F J Gaida, Monoclonal, anti-domain and anti-peptide antibodies assign the molecular weight 160,000 granulocyte membrane antigen of the CD66 cluster to a mRNA species encoded by the biliary glycoprotein gene, a member of the carcinoembryonic antigen gene family. Journal of Immunology. ,vol. 150, pp. 4978- 4984 ,(1993)
Timothy A. Plunkett, Paul A. Ellis, CEACAM1: A Marker With a Difference or More of the Same? Journal of Clinical Oncology. ,vol. 20, pp. 4273- 4275 ,(2002) , 10.1200/JCO.2002.20.21.4273
Ralph H. Hruban, Neal S. Fedarko, Anirban Maitra, Jens Koopmann, Charles J. Yeo, Alka Jain, Ayman Rahman, Michael Goggins, Christine Iacobuzio-Donahue, Evaluation of Osteopontin as Biomarker for Pancreatic Adenocarcinoma Cancer Epidemiology, Biomarkers & Prevention. ,vol. 13, pp. 487- 491 ,(2004)
Ralph H. Hruban, N. Volkan Adsay, Jorge Albores–Saavedra, Carolyn Compton, Elizabeth S. Garrett, Steven N. Goodman, Scott E. Kern, David S. Klimstra, Günter Klöppel, Daniel S. Longnecker, Jutta Lüttges, G. Johan A. Offerhaus, Pancreatic Intraepithelial Neoplasia: A New Nomenclature and Classification System for Pancreatic Duct Lesions The American Journal of Surgical Pathology. ,vol. 25, pp. 579- 586 ,(2001) , 10.1097/00000478-200105000-00003
Claus Niederau, James H. Grendell, Diagnosis of Pancreatic Carcinoma: Imaging Techniques and Tumor Markers Pancreas. ,vol. 7, pp. 66- 86 ,(1992) , 10.1097/00006676-199201000-00011
Eckart Laack, Haleh Nikbakht, Anja Peters, Christian Kugler, Yvonne Jasiewicz, Lutz Edler, Jens Brümmer, Udo Schumacher, Dieter Kurt Hossfeld, Expression of CEACAM1 in Adenocarcinoma of the Lung: A Factor of Independent Prognostic Significance Journal of Clinical Oncology. ,vol. 20, pp. 4279- 4284 ,(2002) , 10.1200/JCO.2002.08.067
Fumihiko Miura, Tadahiro Takada, Hodaka Amano, Masahiro Yoshida, Shigeru Furui, Koji Takeshita, Diagnosis of pancreatic cancer Hpb. ,vol. 8, pp. 337- 342 ,(2006) , 10.1080/13651820500540949